Welcome to our dedicated page for Valuence Merger I SEC filings (Ticker: VMCAF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Valuence Merger Corp. I filings document a Cayman Islands blank-check issuer organized around an initial business combination. Its 8-K reports and proxy materials cover deadline extensions, trust account deposits, redemption mechanics, amendments to its memorandum and articles of association, and shareholder voting procedures.
The filing record also describes sponsor-related financing, including a convertible promissory note, potential conversion into warrants, private-placement warrant terms and obligations payable outside the trust account in certain circumstances. These disclosures frame the company’s capital structure, governance mechanics and business-combination timetable.
Valuence Merger Corp. I (VMCAF) reports that its board of directors approved another one-month extension of the deadline to complete its initial business combination, moving the date from September 3, 2026 to October 3, 2026. This is the fifth of up to ten one-month extensions permitted under its governing documents, which allow extensions, by board resolution, through March 3, 2027. In connection with this extension, the company deposited an additional $13,897.14 into its trust account.
Valuence Merger Corp. I, a Cayman Islands special purpose acquisition company, reported small operating losses for the three and six months ended June 30, 2026, driven by general and administrative expenses of $243,123 for the first half, partially offset by $177,739 of interest income on funds in its Trust Account, resulting in a net loss of $65,384.
Total assets were dominated by the Trust Account balance of $5.9 million, down sharply from prior levels following multiple shareholder redemptions. After the February 2026 meeting, an additional 1,404,164 Class A shares were redeemed for about $17.6 million, leaving 463,238 Class A shares subject to redemption at $12.77 per share.
The company showed a working capital deficit of $5.1 million, with current liabilities of $5.2 million, including $1.87 million of new 2026 convertible promissory notes and earlier working capital loans. These related-party debts were restructured on June 30, 2026 into three new notes that are non-interest bearing and potentially convertible into warrants. Management disclosed that limited cash of $8,795, the deficit position, and the requirement to complete a Business Combination by up to March 3, 2027 raise substantial doubt about the company’s ability to continue as a going concern.
Valuence Merger Corp. I approved another one‑month extension of the deadline to consummate its initial business combination, moving the date from August 3, 2026 to September 3, 2026. The decision was made by the board of directors on August 3, 2026.
This is the fourth of up to 10 available one‑month extensions. In connection with the extension, the company deposited an additional $13,897.14 into its trust account. Under its Amended and Restated Memorandum and Articles of Association, the deadline may be extended monthly by board resolution to as late as March 3, 2027.
Valuence Merger Corp. I restructured its related-party financing arrangements on June 30, 2026. The company and its sponsor terminated an unused February 2026 convertible promissory note with a principal amount of up to $1,500,000, with no amounts ever drawn.
Through an Omnibus Note Exchange and Debt Conversion Agreement, the company canceled a fully drawn June 2024 note with principal of up to $300,000 and settled advances from CPC I, CPC I Parallel and NovoCG totaling $1,570,000. In exchange, it issued three new zero-interest convertible promissory notes with principals of up to $1,500,000, $1,500,000 and $3,000,000, respectively, carrying initial deemed drawdown balances of $528,650, $441,350 and $900,000.
The new notes mature at the earlier of the company’s initial business combination or liquidation and may, at maturity, be converted at the holders’ option into warrants at $1.50 per warrant, subject to an aggregate $1,500,000 cap on conversions of notes held by the sponsor and its affiliates.
Valuence Merger Corp. I reported that its board approved another one-month extension of the deadline to complete an initial business combination, moving the date from July 3, 2026 to August 3, 2026. This is the third of up to ten monthly extensions the company can use under its governing documents, which allow extensions through March 3, 2027. In connection with this extension, Valuence Merger Corp. I deposited an additional $13,897.14 into its trust account, as required under its existing structure.
Valuence Merger Corp. I extended the deadline to complete its initial business combination by one month, moving the date from June 3, 2026 to July 3, 2026. This is the second of up to ten one-month extensions the board can approve.
To support this extension, the company deposited an additional $13,897.14 into its trust account. Under its Amended and Restated Memorandum and Articles of Association, the company may continue extending the deadline monthly, by board resolution, up to March 3, 2027.
Valuence Merger Corp. I reported that director Zhe Zhang resigned from its Board of Directors and its audit committee, effective immediately on May 18, 2026. The company states that his resignation was not due to any dispute or disagreement regarding operations, policies, or practices.
Valuence Merger Corp. I, a SPAC, filed its quarterly report for the three months ended March 31, 2026, showing minimal operations and net income of $8,303 driven by interest on trust funds. The trust account held about $5.8 million after large redemptions, with only 463,238 Class A shares still subject to redemption.
The company has just $2,521 of cash outside the trust and a working capital deficit of about $5.2 million, funded mainly by related-party loans and convertible notes. Management discloses substantial doubt about its ability to continue as a going concern if no business combination is completed by the extended deadline up to March 3, 2027.
Shareholders have repeatedly extended the merger deadline, and sponsors have deposited roughly $2.3 million of extension contributions into the trust. The stock was delisted from Nasdaq in March 2025 and now trades on the OTC Pink market, while the SPAC continues searching for a target in Asian life sciences or sustainable technology.
Valuence Merger Corp. I extended the deadline to complete its initial business combination by one month, moving the date from May 3, 2026 to June 3, 2026. This is the first of up to ten one-month extensions allowed by its governing documents.
To implement the extension, the company deposited an additional $13,897.14 into its trust account. The amended memorandum and articles of association permit further monthly extensions, by board resolution, through March 3, 2027, giving the SPAC more time to identify and close a suitable merger target.
Valuence Merger Corp. I files its annual report detailing its status as a blank check company still seeking an initial business combination. After multiple extensions and heavy redemptions, it has $23.2 million in the trust as of December 31, 2025.
Public shareholders who ultimately liquidate could receive an estimated $12.43 per share, but warrants would expire worthless. Redemptions have reduced Class A shares subject to redemption to 463,238, and the company’s securities have been delisted from Nasdaq and now trade on the OTC Pink.
The report highlights substantial reliance on sponsor loans and extension contributions, ongoing going concern risks if no business combination is completed by the extended deadlines through up to March 3, 2027, and lays out a strategy focused on Asia-based life sciences and sustainable technology targets.